• Double-digit organic sales and EBIT growth in Industrial and Healthcare segments
• KBU acquisition integration completed ahead of schedule, synergies target upgraded
• Accelerated Productivity Investment Program on track, focus shifts to ERP system upgrades

Ansell Ltd delivered a strong set of financial results for FY25, with organic constant currency sales growth of 7.7% and adjusted EPS growth of 19.2%. The company achieved its key performance objectives, including double-digit organic sales and EBIT growth in both the Industrial and Healthcare segments. In the Industrial segment, sales growth was driven by new products and improved manufacturing utilization, while the Healthcare segment rebounded from destocking in the prior year. The integration of the KBU acquisition was completed ahead of schedule, with the synergies target upgraded from $10 million to $15 million. The Accelerated Productivity Investment Program (APIP) remained on track, delivering $47 million in savings in FY25, and the focus is now shifting to the implementation of a unified, cloud-based ERP system across the company's manufacturing and commercial operations. Overall, Ansell demonstrated its ability to execute on its strategic priorities, strengthen its business, and deliver strong financial performance despite the challenging operating environment.

Ansell provided adjusted EPS guidance of US$133 cents to US$145 cents for FY26.

The company is focused on leveraging its market-leading brands, expanding its presence in key growth verticals, and continuing to drive productivity improvements through the APIP and ERP system upgrades. Ansell remains well-positioned to capitalize on industry trends and deliver sustainable growth.